Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study

BACKGROUND: A profound inflammation-mediated lung injury with long-term acute respiratory distress and high mortality is one of the major complications of critical COVID-19. Immunoglobulin M (IgM)-enriched immunoglobulins seem especially capable of mitigating the inflicted inflammatory harm. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmel, Tim, Kraft, Felix, Haberl, Helge, Achtzehn, Ute, Brandenburger, Timo, Neb, Holger, Jarczak, Dominik, Dietrich, Maximilian, Magunia, Harry, Zimmer, Frieda, Basten, Jale, Landgraf, Claudia, Koch, Thea, Zacharowski, Kai, Weigand, Markus A., Rosenberger, Peter, Ullrich, Roman, Meybohm, Patrick, Nierhaus, Axel, Kindgen-Milles, Detlef, Timmesfeld, Nina, Adamzik, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260992/
https://www.ncbi.nlm.nih.gov/pubmed/35799196
http://dx.doi.org/10.1186/s13054-022-04059-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260992/
https://www.ncbi.nlm.nih.gov/pubmed/35799196
http://dx.doi.org/10.1186/s13054-022-04059-0

Ejemplares similares